Kiniksa Pharmaceuticals International (KNSA) Other Non-Current Liabilities (2018 - 2026)
Kiniksa Pharmaceuticals International (KNSA) recorded Other Non-Current Liabilities of $34.02 million in Q2 2026, up 267.3% from $9.26 million a year earlier and up 34.4% from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends
At the end of FY2025, Kiniksa Pharmaceuticals International reported Other Non-Current Liabilities of $18.52 million, up 916.0% from FY2024.
- Annual Other Non-Current Liabilities has a five-year compound annual growth rate of 87.2% (FY2020 to FY2025).
- Across earlier years, Other Non-Current Liabilities came in at $1.82 million in FY2024 (-1.9%), $1.86 million in FY2023 (+1.0%), $1.84 million in FY2022 (+581.1%) and $270,000 in FY2021 (-66.5%).
- The Q2 2026 figure is the highest quarterly Other Non-Current Liabilities in data going back to Q2 2018.
- On a year-over-year basis, Other Non-Current Liabilities has increased for six consecutive quarters, with growth averaging 346.0% over the last eight quarters.
- Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 916.0% in Q4 2025, against a decline of 77.2% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $25.32 million (Q1 2026), $18.52 million (Q4 2025) and $14.53 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Kiniksa Pharmaceuticals International | 11.64 Bn | 10.38 Bn | 220.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.02 Mn |
| Mar 31, 2026 | 25.32 Mn |
| Dec 31, 2025 | 18.52 Mn |
| Sep 30, 2025 | 14.53 Mn |
| Jun 30, 2025 | 9.26 Mn |
| Mar 31, 2025 | 5.14 Mn |
| Dec 31, 2024 | 1.82 Mn |
| Sep 30, 2024 | 1.96 Mn |
| Jun 30, 2024 | 1.93 Mn |
| Mar 31, 2024 | 1.89 Mn |
| Dec 31, 2023 | 1.86 Mn |
| Sep 30, 2023 | 1.95 Mn |
| Jun 30, 2023 | 1.92 Mn |
| Mar 31, 2023 | 1.88 Mn |
| Dec 31, 2022 | 1.84 Mn |
| Sep 30, 2022 | 1.82 Mn |
| Jun 30, 2022 | 260,000.00 |
| Mar 31, 2022 | 271,000.00 |
| Dec 31, 2021 | 270,000.00 |
| Sep 30, 2021 | 885,000.00 |
API Access
Kiniksa Pharmaceuticals International Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();